TTK Healthcare Limited engages in the pharmaceutical, consumer product, medical device, protective device, and food businesses in India and internationally. More Details
+ 1 more risk
Excellent balance sheet unattractive dividend payer.
Share Price & News
How has TTK Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 507747's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 507747 underperformed the Indian Pharmaceuticals industry which returned 50.1% over the past year.
Return vs Market: 507747 underperformed the Indian Market which returned 2.3% over the past year.
Price Volatility Vs. Market
How volatile is TTK Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is TTK Healthcare undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 507747 (₹430.5) is trading above our estimate of fair value (₹131.62)
Significantly Below Fair Value: 507747 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 507747 is poor value based on its PE Ratio (96.9x) compared to the IN Pharmaceuticals industry average (22.8x).
PE vs Market: 507747 is poor value based on its PE Ratio (96.9x) compared to the Indian market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 507747's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 507747 is overvalued based on its PB Ratio (2.4x) compared to the IN Pharmaceuticals industry average (2.2x).
How is TTK Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TTK Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine TTK Healthcare's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- TTK Healthcare competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has TTK Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 507747 has high quality earnings.
Growing Profit Margin: 507747's current net profit margins (1.1%) are lower than last year (3.2%).
Past Earnings Growth Analysis
Earnings Trend: 507747's earnings have declined by 2.8% per year over the past 5 years.
Accelerating Growth: 507747's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 507747 had negative earnings growth (-68.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (14.7%).
Return on Equity
High ROE: 507747's Return on Equity (2.5%) is considered low.
How is TTK Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: 507747's short term assets (₹3.0B) exceed its short term liabilities (₹1.7B).
Long Term Liabilities: 507747's short term assets (₹3.0B) exceed its long term liabilities (₹107.1M).
Debt to Equity History and Analysis
Debt Level: 507747's debt to equity ratio (11.3%) is considered satisfactory.
Reducing Debt: 507747's debt to equity ratio has reduced from 34% to 11.3% over the past 5 years.
Debt Coverage: 507747's debt is well covered by operating cash flow (70.5%).
Interest Coverage: 507747's interest payments on its debt are not well covered by EBIT (1.5x coverage).
What is TTK Healthcare current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 507747's dividend (0.7%) is higher than the bottom 25% of dividend payers in the Indian market (0.56%).
High Dividend: 507747's dividend (0.7%) is low compared to the top 25% of dividend payers in the Indian market (2.3%).
Stability and Growth of Payments
Stable Dividend: 507747's dividend payments have been volatile in the past 10 years.
Growing Dividend: 507747's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (67.5%), 507747's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
T. Raghunathan (68 yo)
Mr. T. T. Raghunathan, B.Com., has been the Chief Executive Officer of TTK Healthcare Limited since August 22, 2014. Mr. Raghunathan has been Managing Director of TTK - LIG Ltd., since February 01, 2013. M ...
CEO Compensation Analysis
Compensation vs Market: T.'s total compensation ($USD146.46K) is above average for companies of similar size in the Indian market ($USD55.70K).
Compensation vs Earnings: T.'s compensation has been consistent with company performance over the past year.
|Executive Vice Chairman & CEO||6.17yrs||₹10.79m||0.27% |
|Wholetime Secretary||6.17yrs||₹11.82m||0.0031% |
|Independent Director||6.17yrs||₹100.00k||no data|
|Non-Executive Director||20yrs||₹300.00k||0.0018% |
|Chairman||no data||₹80.00k||5.37% |
|Independent Director||6.17yrs||₹260.00k||no data|
|Non-Executive Non-Independent Director||35.92yrs||₹140.00k||0.22% |
|Independent Director||5.58yrs||₹120.00k||no data|
|Independent Director||4.67yrs||₹100.00k||no data|
|Independent Director||1.33yrs||₹100.00k||no data|
Experienced Board: 507747's board of directors are considered experienced (6.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
TTK Healthcare Limited's company bio, employee growth, exchange listings and data sources
- Name: TTK Healthcare Limited
- Ticker: 507747
- Exchange: BSE
- Founded: 1958
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹6.147b
- Shares outstanding: 14.13m
- Website: https://www.ttkhealthcare.com
Number of Employees
- TTK Healthcare Limited
- No.6, Cathedral Road
- Tamil Nadu
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|507747||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||May 2001|
|TTKHLTCARE||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||May 2001|
TTK Healthcare Limited engages in the pharmaceutical, consumer product, medical device, protective device, and food businesses in India and internationally. The company’s Pharmaceuticals segment deals in h ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/22 12:54|
|End of Day Share Price||2020/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.